IVIG in autoimmunity and cancer – efficacy versus safety

Author： Sherer Yaniv   Levy Yair   Shoenfeld Yehuda  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.1, Iss.2, 2002-07, pp. : 153-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Versus Intramuscular Phytomenadione: Safety and Efficacy Compared

By von Kries R.  

Drug Safety, Vol. 21, Iss. 1, 1999-07 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Ultrasound contrast agents: balancing safety versus efficacy

By Main Michael L   Goldman Jonathan H   Grayburn Paul A  

Expert Opinion on Drug Safety, Vol. 8, Iss. 1, 2009-01 ,pp. : 49-56

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of HMG versus r-FSH: response

By Al-Inany Hesham  

Reproductive BioMedicine Online, Vol. 16, Iss. 4, 2008-04 ,pp. : 600-600

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Efficacy and safety of HMG versus r-FSH

By Ulug Ulun   Bahçeci Mustafa  

Reproductive BioMedicine Online, Vol. 16, Iss. 4, 2008-04 ,pp. : 599-599

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Botanical medicine and cancer: a review of the safety and efficacy

By Boon Heather   Wong Jacqueline  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2485-2501

Informa Healthcare

Access to resources Recommend Favorite